Artivion
Manufacturing · Georgia, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
1655 Roberts Blvd NW, Kennesaw, Georgia,...Phone Number
(770) 419-3355Website
www.artivion.comRevenue
$458.7 MillionStock Symbol
AORTIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
1
1
1
1
1
About Artivion
Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair.Explore more
Artivion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Artivion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Artivion had a recent Job posting/layoffs
Check out if Artivion is spiking on competitors!
Product Launch: Get notified when Artivion launches new products
Funding: Get notified immidiatlly once Artivion has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Artivion recently announced quarterly report
Check if Artivion has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Artivion
Artivion, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Artivion
Find 3 more new buyers
Compare Similar Companies to Artivion
Compare insights from companies similar to Artivion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Artivion is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Artivion is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Artivion.
Artivion Tech Stack
A closer look at the technologies used by Artivion
See more technologies
Most Recent Scoops
Pain Point
Artivion has reported that, for the first time in Q1, a number of surgeons began deferring AMDS adoption asking to be contacted after PMA approval rather than proceeding under the current HDE pathway representing a new headwind to near-term account conversions not previously encountered in the commercial launch.
CRM, Account Management
Project
Artivion has announced that its NEXUS aortic arch stent graft system, which holds full PMA approval with no HDE restrictions, will be launched without an upfront inventory purchase requirement, and surgeons will have the ability to perform cases on a one-off basis prior to full value analysis committee approval, differentiating the NEXUS commercial launch from the company's prior AMDS launch experience.
Medical Research
Pain Point
Artivion has reported two operational headwinds impacting its current-year outlook: an ongoing revenue impact from the conflict in the Middle East, which the company has addressed by assuming current sales levels hold for the remainder of the year, and a supplier capacity constraint affecting a specific product within its stent graft portfolio, estimated at approximately $3 million.
Pain Point, Sales
Project
Artivion is awaiting PMA approval for its AMDS device, which is expected to expand the addressable market from approximately 40% to the full $150 million US market of roughly 6,000 annual procedures priced at $25,000 per device, covering both clinical and radiographic malperfusion indications.
Product Development, Medical Research, Clinical Operations
Pain Point
Barriers
Artivion News & Media
Artivion to Participate in the 2026 Truist Securities MedTech Conference
ATLANTA, June 10, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate at the upcoming 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026, at the Boston Harbor...Pillsbury Advises Artivion, Inc. on Acquisition of Endospan Ltd.
Pillsbury advised Artivion, Inc. (NYSE:AORT), a leading cardiac and vascular surgery company focused on aortic disease, on its recent acquisition of longstanding partner Endospan Ltd., a pioneer in the endovascular repair of aortic arch disease and developer of the NEXUS® Aortic Arch System.Artivion closes $175M acquisition of aortic arch maker Endospan - MassDevice
Endospan announced today that Artivion completed its $175 million acquisition of the company, following FDA approval for its Nexus system.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Artivion
Sign Up For FreeTo access detailed company insights
Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair.... Read More
